toggle visibility Search & Display Options

Select All    Deselect All
 | 
Citations
 | 
   print
Momeny, M., Moghaddaskho, F., Gortany, N. K., Yousefi, H., Sabourinejad, Z., Zarrinrad, G., et al. (2017). Blockade of vascular endothelial growth factor receptors by tivozanib has potential anti-tumour effects on human glioblastoma cells. Sci Rep, 7, 44075.
toggle visibility
Ludwig, K., & Kornblum, H. I. (2017). Molecular markers in glioma. J Neurooncol, .
toggle visibility
Alshehri, M. M., Robbins, S. M., & Senger, D. L. (2017). The Role of Neurotrophin Signaling in Gliomagenesis: A Focus on the p75 Neurotrophin Receptor (p75NTR/CD271). Vitam Horm, 104, 367–404.
toggle visibility
Bijangi-Vishehsaraei, K., Reza Saadatzadeh, M., Wang, H., Nguyen, A., Kamocka, M. M., Cai, W., et al. (2017). Sulforaphane suppresses the growth of glioblastoma cells, glioblastoma stem cell-like spheroids, and tumor xenografts through multiple cell signaling pathways. J Neurosurg, , 1–12.
toggle visibility
Clark, P. A., Gaal, J. T., Strebe, J. K., Pasch, C. A., Deming, D. A., Kuo, J. S., et al. (2017). The effects of tumor treating fields and temozolomide in MGMT expressing and non-expressing patient-derived glioblastoma cells. J Clin Neurosci, 36, 120–124.
toggle visibility
Select All    Deselect All
 | 
Citations
 | 
   print